These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8578530)

  • 21. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation: in vitro effect of cerivastatin.
    Puccetti L; Bruni F; Di Renzo M; Bova G; Cercignani M; Iadanza A; Auteri A; Pasqui AL
    Eur Rev Med Pharmacol Sci; 1999; 3(5):197-204. PubMed ID: 11075617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
    Poston RS; Gu J; Brown JM; Gammie JS; White C; Nie L; Pierson RN; Griffith BP
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):122-30. PubMed ID: 16399303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of CD 62P expression in patients with acute myocardial infarction.
    Dymicka-Piekarska V; Kemona H; Mantur M; Stogowski A; Kemona-Chetnik I; Bychowski J
    Rocz Akad Med Bialymst; 2000; 45():104-15. PubMed ID: 11712421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of thrombin generation in whole blood--the effect of heparin and aspirin.
    Kessels H; Béguin S; Andree H; Hemker HC
    Thromb Haemost; 1994 Jul; 72(1):78-83. PubMed ID: 7974380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thrombin generation by aspirin.
    Szczeklik A
    Thromb Haemost; 1994 Dec; 72(6):988-9. PubMed ID: 7740476
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thrombin as a common target of action for antithrombotic drugs in vivo].
    Ma X
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):646-8. PubMed ID: 1963361
    [No Abstract]   [Full Text] [Related]  

  • 30. Controversies in cardiology. Proposed: low-dose aspirin should be taken daily after age 40 if total serum cholesterol is greater than 160.
    Schoenberger JA; Mann GV
    Hosp Pract (Off Ed); 1982 Dec; 17(12):50A, 50D, 50F passim. PubMed ID: 6815063
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction.
    Szczeklik A; Dropiński J; Góra PF
    Coron Artery Dis; 1993 Nov; 4(11):1029-32. PubMed ID: 8173709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High levels of cholesterol and lipoprotein (A) in serum decreases the inhibitory effect of aspirin on generation of thrombin].
    Szczeklik A; Musiał J; Undas A; Swadźba J; Duplaga M; Grzywacz M
    Pol Arch Med Wewn; 1995 Jun; 93(6):483-9. PubMed ID: 7491348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More on: aspirin resistance.
    Szczeklik A; Undas A
    J Thromb Haemost; 2004 Aug; 2(8):1489. PubMed ID: 15304070
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous heparin--a protective marker in patients with myocardial infarction.
    Władysław S
    Coron Artery Dis; 2002 Dec; 13(8):423-6. PubMed ID: 12544717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced spontaneous thrombolysis: a new therapeutic challenge.
    Kovacs IB; Gorog DA; Yamamoto J
    J Thromb Thrombolysis; 2006 Jun; 21(3):221-7. PubMed ID: 16683213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma.
    Szczeklik A; Schmitz-Schumann M; Krzanowski M; Virchow C
    Clin Exp Allergy; 1991 Jul; 21(4):411-5. PubMed ID: 1913263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombin and anti-thrombin antibody levels in the blood of patients with acute myocardial infarction].
    Korochkin IM; Verbitskaia IA; Tugutov AN; Miagkova MA; Polevaia OIu
    Kardiologiia; 1990 Jan; 30(1):45-8. PubMed ID: 2335864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin to Reduce Risk for Sudden Cardiac Death in Athletes With Elevated C-Reactive Protein Levels.
    Siegel AJ
    Am J Med; 2020 Sep; 133(9):1014-1016. PubMed ID: 32360116
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative analysis of thrombin and anti-thrombin antibody levels in donors and myocardial infarction patients].
    Polevaia OIu; Miagkova MA; Berbitskaia IA; Tugutov AV; Korochkin IM
    Gematol Transfuziol; 1990 Sep; 35(9):8-10. PubMed ID: 2272456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose aspirin, thrombin, and coronary angioplasty.
    Andreotti F; Davies GJ; Ujang SB; Sritara P; Kluft C; Maseri A
    Lancet; 1993 May; 341(8853):1161. PubMed ID: 8097853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.